CAJ | 학술논문

应用Cochrne协作网和保存系统评价的专用分析软件RevMan4.2进行Meta分析,对1982年至今我国公开发表的运用雷公藤制剂辅助或联合其他药物治疗系统性红斑狼疮的文献进行临床疗效的综合评价分析.结果表明,符合并纳入该次Meta分析的文献共有九篇,经卡方检验OR=0.26（95%CI为0.16～0.40）,OR值大于零,且＂漏斗图＂图形基本对称并偏向对照组,表明雷公藤制剂治疗系统性红斑狼疮有较为明显的效果.
응용Cochrne협작망화보존계통평개적전용분석연건RevMan4.2진행Meta분석,대1982년지금아국공개발표적운용뢰공등제제보조혹연합기타약물치료계통성홍반랑창적문헌진행림상료효적종합평개분석.결과표명,부합병납입해차Meta분석적문헌공유구편,경잡방검험OR=0.26（95%CI위0.16～0.40）,OR치대우령,차＂루두도＂도형기본대칭병편향대조조,표명뢰공등제제치료계통성홍반랑창유교위명현적효과.
In the present study, meta analysis is conducted with the use of Cochrne cooperative network and the specialized analysis software RevMan4.2 for preserving systematic evaluation, aiming at the synthetical evaluation and the analysis of full-text documents published in China from 1982 up to now concerning the use of Mongolian gerbilsin either to assist the treatment of or to be combined with other drugs to treat systemic lupus erythemalosus. The results show that there are nine of the documents which are consistent with and included in this meta analysis method. The synthesized analysis results indicate that the OR is 0.26（95 % CI,0.16-0.40）, which is greater than zero visible. It can clearly be seen that Mongolian gerbilsin has played a certain role in the treatment of systemic lupus erythemalosus.